Enlarge / Martin Shkreli (credit: Drew Angerer/Getty Images)

Godel Systems is the company’s name, and a job posting for the company notes that its founder is “an elite entrepreneur” with a “tremendous track record.” A filing with the Securities and Exchange Commission, unearthed by CNBC, said Godel Systems has already raised $50,000. The issued debt is convertible to “equity securities.”

Shkreli came to public attention—and scorn—in 2015 when Turing Pharmaceuticals, the second pharma company he founded, dramatically hiked the price of the life-saving drug Daraprim. The decades-old drug is used to treat a parasitic infection and is often given to AIDS patients and babies. The price increase brought attention to the skyrocketing costs of drugs, and it also opened up a host of criminal legal troubles for Shkreli.